Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Sona Nanotech Inc > Trade Resumption
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(217)
•••
Comment by stingray88on Dec 31, 2020 6:33pm
165 Views
Post# 32206063

RE:RE:RE:RE:RE:Trade Resumption

RE:RE:RE:RE:RE:Trade Resumption
Moemoney42 wrote: Looks like a strong close today... went for coffee to come back and see my $4 target hit... ;-) 
I'm a happy camper..!! How about you stingray..? I traded it a couple of times for nice gains and then finally just decided to hold my last position for Monday. Did well today as did most!
Moemoney42 wrote: 3rd halt today.. and bids building.. easy close over $3 maybe even $4..?
Moemoney42 wrote: Wouldn't be surprised to see it close over $3 today stingray.. ;-)
stingray88 wrote:
Moemoney42 wrote: Gonna be a nice pop this AM... glad I bought back in at $.99... could get interesting today... how many halts before the end of the day..?

i too averaged down at the $1 range. This is still very undervalued with this news. Any ptrojections Moe?

 

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities